Abstract

Central auditory processing disorder (CAPD) is associated with difficulties hearing and processing acoustic information, as well as subsequent impacts on the development of higher-order cognitive processes (i.e., attention and language). Yet CAPD also lacks clear and consistent diagnostic criteria, with widespread clinical disagreement on this matter. As such, identification of biological markers for CAPD would be useful. A recent genome association study identified a potential CAPD risk gene, USH2A. In a homozygous state, this gene is associated with Usher syndrome type 2 (USH2), a recessive disorder resulting in bilateral, high-frequency hearing loss due to atypical cochlear hair cell development. However, children with heterozygous USH2A mutations have also been found to show unexpected low-frequency hearing loss and reduced early vocabulary, contradicting assumptions that the heterozygous (carrier) state is “phenotype free”. Parallel evidence has confirmed that heterozygous Ush2a mutations in a transgenic mouse model also cause low-frequency hearing loss (Perrino et al., 2020). Importantly, these auditory processing anomalies were still evident after covariance for hearing loss, suggesting a CAPD profile. Since usherin anomalies occur in the peripheral cochlea and not central auditory structures, these findings point to upstream developmental feedback effects of peripheral sensory loss on high-level processing characteristic of CAPD. In this study, we aimed to expand upon the mouse behavioral battery used in Perrino et al. (2020) by evaluating central auditory brain structures, including the superior olivary complex (SOC) and medial geniculate nucleus (MGN), in heterozygous and homozygous Ush2a mice. We found that heterozygous Ush2a mice had significantly larger SOC volumes while homozygous Ush2a had significantly smaller SOC volumes. Heterozygous mutations did not affect the MGN; however, homozygous Ush2a mutations resulted in a significant shift towards more smaller neurons. These findings suggest that alterations in cochlear development due to USH2A variation can secondarily impact the development of brain regions important for auditory processing ability.

Highlights

  • Individuals diagnosed with central auditory processing disorder (CAPD) experience difficulties with multiple mechanisms that subserve acoustic information processing

  • The study was based on human clinical evidence that homozygous mutations of USH2A result in Usher syndrome type 2 [13], as well as recent evidence that heterozygous USH2A mutations may be a genetic risk factor for CAPD [24]

  • Results showed that heterozygous Ush2a mutations resulted in an increase in right superior olivary complex (SOC) volume, while homozygous Ush2a mutations resulted in a decrease in right SOC volume, as well as a shift towards fewer large and more small neurons in the right medial geniculate nucleus (MGN)

Read more

Summary

Introduction

Individuals diagnosed with central auditory processing disorder (CAPD) experience difficulties with multiple mechanisms that subserve acoustic information processing. These include, but are not limited to, sound localization, temporal discrimination, discrimination between two or more competing auditory stimuli, auditory pattern recognition and dichotic listening [1,2]. Affected individuals have difficulties with speech processing that include attending to verbal input (i.e., oral instruction) and comprehending complex sentences [3]. There is ongoing debate within the audiology community as to the definition of—and diagnostic criteria for—CAPD. This includes whether CAPD should be considered a DSM-defined disorder.

Objectives
Methods
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call